Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    SEC Filing Details

    SEC Filing Details

    Document Details

    Form
    10-Q
    Filing Date
    Aug 14, 2019
    Document Date
    Jun 30, 2019
    Form Description
    Quarterly report which provides a continuing view of a company's financial position
    Filing Group
    Quarterly Filings
    Company
    Daré Bioscience
    Issuer
    DARE BIOSCIENCE, INC.

    Filing Formats

    View HTML
    Download PDF
    Download DOC
    Download XLS

    XBRL

    XBRL Viewer
    EX-101.INS - XBRL INSTANCE DOCUMENT
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
    EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
    EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
    EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
    EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top